Featured Research

from universities, journals, and other organizations

New Alzheimer’s Treatment Under Study At Medical College Of Georgia

Date:
July 2, 2004
Source:
Medical College Of Georgia
Summary:
A new drug that appears to improve learning and memory in animals and may reduce the accumulation of destructive plaque that is the hallmark of Alzheimer’s disease is under study at the Medical College of Georgia.

Dr. Jeffrey L. Rausch is enrolling patients in an international trial of a new treatment for Alzheimer's disease.
Credit: Photo courtesy of Medical College Of Georgia

A new drug that appears to improve learning and memory in animals and may reduce the accumulation of destructive plaque that is the hallmark of Alzheimer’s disease is under study at the Medical College of Georgia.

Related Articles


MCG is enrolling Alzheimer’s patients with mild to moderate memory loss in a 12-week study that compares different doses of the drug - still known only by a number - to placebo. The study is being conducted at approximately 40 sites worldwide, including 34 sites in the United States.

“We want to see if this drug will improve cognition or memory in Alzheimer’s disease,” said Dr. Jeffrey L. Rausch, psychiatrist, vice chair of the MCG Department of Psychiatry and Health Behavior and a principal investigator on the study.

The drug, developed by Sanofi-Synthelabo, Inc., in France, has been shown in published studies to improve episodic memory (using an object recognition task) and to reverse learning decline in aging rats, Dr.Rausch said.

Previous clinical trials have suggested the drug is safe in humans; the current study will look at its efficacy and safety.

The drug is among the first to target 5HT4 receptors, one of the numerous receptors that regulates serotonin, a neurotransmitter that enables cells to communicate. Patients with clinical depression often have too little serotonin activity. Many antidepressants work by maximizing the serotonin patients do have.

Although there is no evidence that Alzheimer’s disease directly affects 5HT4 receptors, there is some common ground. 5HT4 activity is associated with an increased excretion of a soluble form of the amyloid precursor protein sAPPá.

However, the insoluble form of this protein deposits in plaques in the brains of Alzheimer’s patients. “Stimulation of the 5HT4 receptors appears to be neuroprotective and memory enhancing in animals,” Dr. Rausch says. Soluble amyloid protein, which can move easily around cells without getting stuck, has antioxidant properties for scavenging free radicals and other potentially destructive trash in the brain.

The new drug under study appears to have a synergistic action with acetylcholinesterase (AChE) inhibitors, which are used to treat symptoms of Alzheimer's disease and which regulate the acetylcholine system, a major neurotransmitter system. A progressive loss of acetylcholine is considered a major culprit in the memory loss that accompanies Alzheimer's; some of the Alzheimer’s drugs already on the market also work to increase acetylcholine, Dr. Rausch said.

This new drug stimulates 5HT4 receptors which are critical to memory and adaptation to the environment. Dr. Rausch noted that Alzheimer’s patients often become irritable and inflexible as their disease progresses, functioning best in a familiar environment and often unable to adjust to a new one. “If you put them in a new environment, their ability to learn and adapt to new things is not there and you may see more dysfunction,” he said.

“We hope this new drug, which is among the first to target this particular serotonin receptor, will indicate a new way of treating this devastating disease,” Dr. Rausch said. “If the study finds the drug successful, perhaps it can one day be used to delay disease progression until a cure for Alzheimer’s can be found.”

For more information about the study, call coordinator Kay Bingham at (706) 721-7835.


Story Source:

The above story is based on materials provided by Medical College Of Georgia. Note: Materials may be edited for content and length.


Cite This Page:

Medical College Of Georgia. "New Alzheimer’s Treatment Under Study At Medical College Of Georgia." ScienceDaily. ScienceDaily, 2 July 2004. <www.sciencedaily.com/releases/2004/07/040701084400.htm>.
Medical College Of Georgia. (2004, July 2). New Alzheimer’s Treatment Under Study At Medical College Of Georgia. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2004/07/040701084400.htm
Medical College Of Georgia. "New Alzheimer’s Treatment Under Study At Medical College Of Georgia." ScienceDaily. www.sciencedaily.com/releases/2004/07/040701084400.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins